| Severity of HA | Mild (n = 33) | Moderate (n = 66) | Severe (n = 88) | TOTAL (n = 187) |
|---|---|---|---|---|
| Receiving factor replacement therapy, n (%) | 8 (24%) | 25 (38%) | 88 (100%) | 121 (65%) |
| Primary on‐demand | 8 (100%) | 20 (80%) | 37 (42%) | 65 (54%) |
| Primary prophylaxis | 0 (0%) | 0 (0%) | 10 (11%) | 10 (8%) |
| Secondary on‐demand | 0 (0%) | 5 (20%) | 6 (7%) | 11 (9%) |
| Secondary prophylaxis | 0 (0%) | 0 (0%) | 35 (40%) | 35 (29%) |
| Annualised bleed rate, mean ± SD | 1.09 ± 0.96 | 2.77 ± 3.57 | 4.58 ± 10.65 | 3.34 ± 7.73 |
| Target joints, mean ± SD | 0.06 ± 0.24 | 0.53 ± 0.83 | 1.00 ± 1.30 | 0.67 ± 1.08 |
| Problem joints, mean ± SD | 0.33 ± 0.48 | 0.86 ± 1.18 | 0.78 ± 1.12 | 0.73 ± 1.07 |
| EQ‐5D‐5L, n; mean ± SD | 15; 0.87 ± 0.19 | 28; 0.81 ± 0.15 | 55; 0.77 ± 0.19 | 98; 0.80 ± 0.18 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.